Cargando…
Increased serum p53 antibody levels indicate poor prognosis in patients with colorectal cancer.
Serum p53 antibody levels were analysed using an enzyme-linked immunosorbent assay in serum samples obtained before surgery from 184 consecutive patients with primary colorectal cancer. Possible associations with tumour stage and tumour differentiation and the relation to patient survival time after...
Autores principales: | Kressner, U., Glimelius, B., Bergström, R., Påhlman, L., Larsson, A., Lindmark, G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150331/ https://www.ncbi.nlm.nih.gov/pubmed/9667657 |
Ejemplares similares
-
Stromal tenascin distribution as a prognostic marker in colorectal cancer.
por: Kressner, U., et al.
Publicado: (1997) -
Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor
por: Salahshor, S, et al.
Publicado: (1999) -
Antibodies against p53 are associated with poor prognosis of colorectal cancer.
por: Houbiers, J. G., et al.
Publicado: (1995) -
The association of preoperative serum tumour markers with Dukes' stage and survival in colorectal cancer.
por: Lindmark, G., et al.
Publicado: (1995) -
Systematic heterogeneity and prognostic significance of cell proliferation in colorectal cancer.
por: Palmqvist, R., et al.
Publicado: (1998)